Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $273
Portfolio Pulse from richadhand@benzinga.com
Guggenheim analyst Sandy Draper maintains a 'Buy' rating on Medpace Holdings (NASDAQ:MEDP) and raises the price target from $252 to $273.
July 25, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst maintains a 'Buy' rating on Medpace Holdings and raises the price target to $273.
The raised price target by Guggenheim indicates a positive outlook for Medpace Holdings. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100